Pfizer, Inc. (NYSE:PFE)

CAPS Rating: 4 out of 5

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.


Player Avatar Snugglah (< 20) Submitted: 5/7/2013 12:20:49 PM : Outperform Start Price: $27.15 PFE Score: -10.03

new drugs & baby boomers - I think this is a winning combination.

Member Avatar EllenBrandtPhD (< 20) Submitted: 5/9/2013 7:16:28 AM
Recs: 0

I'm posting this here just because the Comments feature on Fool's stories is not working AGAIN! That's AGAIN!

This is a short-term trading comment, not a long-term investing comment.

Fool is now porting a story on "Yesterday's Dow Losers," which pretty ridiculously includes PFE, without the author apparently knowing that PFE was ex-divi yesterday.

Stock actually held up VERY well for an ex-divi day, as every intelligent observer knows.

And big news, from a trading standpoint, is PFE's featured presentation at the MS Conference on Friday midday. If those attending like it, and it gets good press, PFE should put in another little rally before and/or immediately after the weekend.

Not a lock, but let's see what we shall see.

In any case, Fool should have edited that story about "Yesterday's Dow Losers" and prominently included the important fact that PFE went ex-divi overnight Tuesday into Wednesday.

Featured Broker Partners